Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment
Abstract
Objectives The prognostic impact of surgical intervention for recurrent or residual non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) rearrangement after tyrosine-kinase inhibitor (TKI) treatment remains unclear. We aimed to describe the characteristics and outcomes of patients undergoing salvage surgery in this setting. Methods We retrospectively collected and...
Paper Details
Title
Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment
Published Date
Mar 1, 2021
Journal
Volume
153
Pages
108 - 116
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History